Pinned Tweet
On the importance of dissemination and communication is Science.
Glycans and Glycosciences: an intro for everyone
innogly.eu/glycans-and-glyco…
#glycotime
INNOGLY COST Action retweeted
FAM20B phosphorylates Xyl of the matriglycan primer disaccharide and dystroglycan has an unexpected xylose phosphatase function involved in regulating matriglycan extension. #glycotime
science.org/doi/10.1126/scie…
INNOGLY COST Action retweeted
Freedom of scientific inquiry: reclaiming space for controversy dlvr.it/TSKgk2
INNOGLY COST Action retweeted
Ticks and sugars #glycotime
Alpha-Gal: The Sugar Humans Lost, and the Allergy That Found Us entomologytoday.org/2026/04/…
INNOGLY COST Action retweeted
New online! Reverse vaccinology 3.0 dlvr.it/TRR35t
INNOGLY COST Action retweeted
Want to know how cancer vaccines can keep you alive?
Very pleased to join several luminaries in the field to offer a comprehensive review on this important topic.
@harvardmed @BostonChildrens #cancer #vaccine
nature.com/articles/s41591-0…
INNOGLY COST Action retweeted
Very proud of @Kwon_Dongil, @sachinbhag, and Stephen Ehrenzeller for putting together a new review - "Harnessing mucosal immunity for protective vaccines" published today @NatRevImmunol!
Please use the link below to access this review 📖
rdcu.be/e4eEU
INNOGLY COST Action retweeted
Harnessing mucosal immunity for protective vaccines dlvr.it/TQzxPG
INNOGLY COST Action retweeted
5 clinical trials to watch in 2026
Ras inhibition in pancreatic cancer, new approaches for prevention of heart disease, Retatrutide vs. Tirzepatide for obesity, and a next-generation antibody in Alzheimer's disease
Read it here: breakingground.substack.com/…
INNOGLY COST Action retweeted
10 breakthroughs in medicine in 2025
Read it here: breakingground.substack.com/…
INNOGLY COST Action retweeted
Discovery of a new checkpoint of cancer cells, a pathway to block and enhance immunotherapy
cell.com/cell-reports/fullte…
INNOGLY COST Action retweeted
Download our large database of funding opportunities for early-career faculty and researchers
Download it here: research.jhu.edu/rdt/funding…
433 funding opportunities.
INNOGLY COST Action retweeted
great paper from the neapolitan Crew!!!
Decoding a Gut Commensal Signal: Structural and Immunological Profiling of Segatella Copri Lipopolysaccharide @di_flaviana @AlbaSilipo @FabrizioChiodo onlinelibrary.wiley.com/doi/…
INNOGLY COST Action retweeted
great paper stunning structures and biology
@AlbaSilipo @di_flaviana
Chemical Synthesis of Arabinogalactans from the Mycobacterium tuberculosis Cell Wall up to the 92‐mer and Structure–Conformation–Activity Relationship Studies
onlinelibrary.wiley.com/doi/…
INNOGLY COST Action retweeted
Protein glycosylation: an emerging regulator of allergic diseases
tinyurl.com/bdw7j958
#gtlycotime
INNOGLY COST Action retweeted
Just in case any one is wondering: Biomedical scientists spend an average of 12 years in training before reaching an independent position. That is more than most medical residences.
INNOGLY COST Action retweeted
Sugar coats shield immunogenic RNA modification: A new function for RNA glycosylation: Molecular Cell cell.com/molecular-cell/full… @VinnieViruses
INNOGLY COST Action retweeted
Finally, someone has solved a real problem with AI! No more having to take a paper in the format for a journal that rejected you, and reformat it for a new journal. Well done!!
formatmypaper.com/
INNOGLY COST Action retweeted
meta-PAMPs: A new class of immunostimulatory molecules that control the ability of bacterial factors to operate as PAMPs. Jordan Jastrab reveals that wall teichoic acid (WTA) is a key regulator of inflammasomes and interferons during infection.
biorxiv.org/content/10.1101/…
INNOGLY COST Action retweeted
bioRxiv has a dedicated section for negative results.
Use it.
Share negative results.
Your colleagues will appreciate it.
INNOGLY COST Action retweeted
Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape bit.ly/3KbHowV
























